a preclinical stage pharmaceutical company, which engages in the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors.
Industry Biotechnology
A.I.dvisor tells us that CNSP and PTGX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNSP and PTGX's prices will move in lockstep.
Ticker / NAME | Correlation To CNSP | 1D Price Change % | ||
---|---|---|---|---|
CNSP | 100% | -3.94% | ||
PTGX - CNSP | 27% Poorly correlated | -3.45% | ||
NRIX - CNSP | 26% Poorly correlated | -1.35% | ||
VIGL - CNSP | 25% Poorly correlated | +2.30% | ||
CALC - CNSP | 25% Poorly correlated | +7.67% | ||
RENB - CNSP | 23% Poorly correlated | -12.63% | ||
More |